Inc. announced that it has completed the first commercial cell collection for Lyfgenia (lovotibeglogene autotemcel), a one-time gene therapy for the treatment of sickle cell disease in patients with a ...
RedHill Biopharma’s opaganib as a therapy for Ebola virus receives Chinese patent: Tel-Aviv, Israel Tuesday, May 7, 2024, 15:00 Hrs [IST] RedHill Biopharma Ltd., a specialty bio ...
Our Bureau, Mumbai Tuesday, May 7, 2024, 15:45 Hrs [IST] ...
Mediar begins patient dosing in US FDA approved phase 1 trial of MTX-463: Boston Tuesday, May 7, 2024, 16:00 Hrs [IST] Mediar Therapeutics, Inc., a biotechnology company advancing ...
Stockholm, Sweden Tuesday, May 7, 2024, 14:00 Hrs [IST] ...
IIHMR University has 200 healthcare start-ups from across India to come under its Saamarthya 2.O ...
Naprod Life Sciences successfully renews EU-GMP certification for its Palghar facility: Our Bureau, Mumbai Tuesday, May 7, 2024, 16:30 Hrs [IST] Naprod Life Sciences has announced ...
UroGen Pharma highlights results of sub-analysis from first and largest real-world patient cohort review of Jelmyto for pyelocalyceal solution: Princeton Tuesday, May 7, 2024, 13: ...
Alkem Labs collaborates with 100 hospitals in tier-1 & tier-2 cities under its 'Reliever Free India' initiative on World Asthma Day: Our Bureau, Mumbai Tuesday, May 7, 2024, 11:30 ...
NephroPlus raises Rs. 850 crore in series F round from Quadria Capital: Our Bureau, Mumbai Tuesday, May 7, 2024, 11:45 Hrs [IST] Quadria Capital (Quadria), one of Asia’s largest ...
Cipla’s Breathefree initiative works on empowerement across the care continuum this asthma awareness month in May. The significance of effective asthma management comes into sharp focus amidst the ...
Boehringer Ingelheim shares positive data from HORNBILL phase I/IIa study of BI 764524 to treat diabetic macular ischemia: Ingelheim, Germany Tuesday, May 7, 2024, 12:00 Hrs [IST] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results